Adrian Adams
-
Auxilium Execs To Reap Millions From Endo Buyout
In the coming days when Endo International closes on its $2.6 billion buyout of the successful men’s health specialty biopharmaceutical company just up the road in…
-
Auxilium Tells Endo Its Not Ready To Be Acquired, Yet
Auxilium Pharmaceuticals of Chesterbrook says its merger with Canadian biotechnology firm QLT stands firm and it is rejecting Endo International’s proposal to acquire all of…
-
Auxilium Sales Plunge Costs A Third Of Its Chesterbrook Workforce
Approximately 190 Auxilium Pharmaceuticals employees are out of a job after sales of the company’s flagship testosterone replacement therapy drug went limp. In response to a…
-
Auxilium Pharmaceuticals Has Merged With QLT Of Vancouver
Auxilium Pharmaceuticals, Inc. of Chesterbrook has merged with QLT, Inc. of Vancouver, British Columbia. QLT is a biotechnology company focused on developing innovative ophthalmology products…
-
Auxilium Pharmaceuticals Announces Departure Of Chief Financial Officer
More trying times for Auxilium Pharmaceuticals, Inc. of Chesterbrook? The specialty biopharmaceutical company on June 2nd announced the impending departure of James E. Fickenscher, the…
-
Chesterbrook Pharma Anticipates Growth, New Products In 2014
Representatives from Auxilium Pharmaceuticals, Inc. of Chesterbrook rang the Nasdaq opening bell on Feb. 26 and also announced to investors solid financial results for 2013.…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
